SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE
Sun Pharma Advanced Research Company Limited Complete list of announcements declared & dividend announcements by Sun Pharma Advanced Research Company Limited SPARC
Sun Pharma Advanced Research Company Limited SPARC listed on NSE and deals in PharmaceuticalsAnnouncements and dividends declared by Sun Pharma Advanced Research Company Limited SPARC
Organon gives Sun Pharma scale and reach, but challenge lies in integration, execution
Sun Pharma has acquired Organon & Co for .75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It also offers diversification into new segments like women's health and biosimilars. The acquisition is expected to
Announcement as on 28 April 2026
Sun Pharma-Organon deal: How a -billion merger will reshape India's pharma landscape
Sun Pharma is set to nearly double its revenue to billion with the acquisition of Organon, creating a global pharmaceutical giant. The deal leverages Organon's strengths in women's health, biosimilars, and established brands, aiming for significant gro
Announcement as on 28 April 2026
Sun Pharma deal structurally strong, debt the only overhang: Amit Khurana
Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma's acquisition is seen as strategically sound, though debt requires careful management. Paytm Payments Bank's license cancellation has limited impact on its
Announcement as on 27 April 2026
Sun Pharma: How a small Kolkata trader became a global buyout artist
Sun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a .5 billion deal for Organon & Co. This move continues Shanghvi's proven strategy of acquiring companies to fuel growth and global expansion. His approach prioritize
Announcement as on 27 April 2026
Sun Pharma to buy Organon in .75 billion all-cash deal
Sun Pharmaceutical Industries has agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately .75 billion, including debt. The agreement stipulates Sun Pharma will purchase all outstanding Organon shares for .00 per
Announcement as on 27 April 2026
Announcements by Sun Pharma Advanced Research Company Limited first page | Next page | Prev page |
SPARC Sun Pharma Advanced Research Company Limited current price & indicator signals
Recent prices of SPARC Sun Pharma Advanced Research Company Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 30 Tue Jun 2026 | 234.75 | 232.34 to 237.40 | 1.54% | 0.39 times |
| 29 Mon Jun 2026 | 231.19 | 220.05 to 232.90 | 2.79% | 0.59 times |
| 25 Thu Jun 2026 | 224.92 | 223.00 to 233.18 | -0.86% | 0.67 times |
| 24 Wed Jun 2026 | 226.86 | 224.45 to 247.95 | -3.43% | 1.67 times |
| 23 Tue Jun 2026 | 234.92 | 234.00 to 244.75 | -1.31% | 0.67 times |
| 22 Mon Jun 2026 | 238.03 | 236.14 to 242.50 | -0.03% | 0.41 times |
| 19 Fri Jun 2026 | 238.09 | 236.00 to 245.69 | -1.81% | 0.61 times |
| 18 Thu Jun 2026 | 242.47 | 233.50 to 253.17 | 1.19% | 2.01 times |
| 17 Wed Jun 2026 | 239.61 | 236.00 to 243.99 | 0.5% | 1.02 times |
| 16 Tue Jun 2026 | 238.41 | 230.25 to 240.80 | 4.1% | 1.05 times |
| 15 Mon Jun 2026 | 229.03 | 220.26 to 233.90 | 2.36% | 1.31 times |
| 12 Fri Jun 2026 | 223.76 | 205.81 to 224.52 | 9.63% | 2.63 times |
Videos related to: SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance


